Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

60.18
+0.36000.60%
Post-market: 60.00-0.1800-0.30%19:58 EST
Volume:10.68M
Turnover:639.03M
Market Cap:122.12B
PE:-13.63
High:60.70
Open:59.94
Low:59.03
Close:59.82
Loading ...

Bristol-Myers Squibb Co - Study Met Key Secondary Endpoint of Complete Response Rate

THOMSON REUTERS
·
10 Feb

Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (Lisocabtagene Maraleucel) in Adult Patients With Relapsed or Refractory Marginal Zone Lymphoma

THOMSON REUTERS
·
10 Feb

Bristol-Myers Squibb Co - Breyanzi Showed Durable Responses and Consistent Safety Profile

THOMSON REUTERS
·
10 Feb

Bristol-Myers Squibb Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
08 Feb

Bristol-Myers Squibb Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
07 Feb

Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $67 From $65

MT Newswires Live
·
07 Feb

Bristol-Myers Squibb (BMY) Gets a Hold from Citi

TIPRANKS
·
07 Feb

Bristol-Myers Squibb Co : Leerink Partners Cuts Target Price to $68 From $73

THOMSON REUTERS
·
07 Feb

Bristol-Myers Squibb: Hold Rating Amid Restructuring and Revenue Challenges

TIPRANKS
·
07 Feb

S&P 500 Gains For 3rd Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone

Benzinga
·
07 Feb

Bristol-Myers Squibb Co (BMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
07 Feb

Q4 2024 Bristol-Myers Squibb Co Earnings Call

Thomson Reuters StreetEvents
·
07 Feb

Bristol Myers Squibb Reports Strong 2024 Financial Growth

TIPRANKS
·
07 Feb

Health Care Climbs After Lilly Earnings - Health Care Roundup

Dow Jones
·
07 Feb

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
07 Feb

Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
07 Feb